scholarly journals Malignancy of hematopoetic system in the elderly-acute myelogenous leukemia-

2004 ◽  
Vol 41 (2) ◽  
pp. 131-140
Author(s):  
Mayumi Mori
Hematology ◽  
2010 ◽  
Vol 2010 (1) ◽  
pp. 62-69 ◽  
Author(s):  
Selina M. Luger

Abstract Decisions regarding the optimal treatment of acute myelogenous leukemia in the elderly patient requires the consideration of multiple factors. Population-based studies have demonstrated that, for all age groups, aggressive therapy results in improved survival and quality of life when compared with palliative care. The optimal induction and postremission regimen for older patients has yet to be determined. Furthermore, not all patients are candidates for such therapy. Consideration of patient and disease-related factors can help to determine the appropriateness of intensive therapy in a given patient. For those patients for whom aggressive induction therapy does not seem to be in their best interest, novel agents are being investigated that will hopefully address the issues of induction death and early relapse associated with these patient populations.


1992 ◽  
Vol 7 (sup2) ◽  
pp. 4-7 ◽  
Author(s):  
Felicetto Ferrara ◽  
Giuseppina Mele ◽  
Vincenzo Mettivier ◽  
Salvatore Mirto ◽  
Renato Cimino

1992 ◽  
Vol 10 (5) ◽  
pp. 251-260 ◽  
Author(s):  
Renato Bassan ◽  
Maurizio Buelli ◽  
Piera Viero ◽  
Clara Minotti ◽  
Tiziano Barbui

1992 ◽  
Vol 40 (3) ◽  
pp. 277-284 ◽  
Author(s):  
Oscar Ballester ◽  
Lynn C. Moscinski ◽  
Daniel Morris ◽  
Lodovico Balducci

2003 ◽  
Vol 10 (6) ◽  
pp. 469-477 ◽  
Author(s):  
Ramalingam Rathnasabapathy ◽  
Jeffrey E. Lancet

1999 ◽  
Vol 34 (5-6) ◽  
pp. 561-567 ◽  
Author(s):  
Marion Baudard ◽  
Ollivier Legrand ◽  
Jean-Pierre Marie ◽  
Robert Zittoun

Sign in / Sign up

Export Citation Format

Share Document